相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Predictive factors, preventive implications, and personalized surgical strategies for bone metastasis from lung cancer: population-based approach with a comprehensive cancer center-based study
Xianglin Hu et al.
EPMA JOURNAL (2022)
A Simple-To-Use Nomogram for Predicting Early Death in Metastatic Renal Cell Carcinoma: A Population-Based Study
Tao Chen et al.
FRONTIERS IN SURGERY (2022)
Risk factors of skeletal-related events in patients with bone metastasis from non-small cell lung cancer undergoing treatment with zoledronate-a post hoc analysis of a randomized clinical trial
Hirotaka Miyashita et al.
SUPPORTIVE CARE IN CANCER (2021)
Analysis of the Mechanism and Safety of Bisphosphonates in Patients with Lung Cancer and Bone Metastases
Gao Zhang et al.
COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Systemic Immune Activation and Responses of Irradiation to Different Metastatic Sites Combined With Immunotherapy in Advanced Non-Small Cell Lung Cancer
Min Wu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Prediction of overall survival of non-small cell lung cancer with bone metastasis: an analysis of the Surveillance, Epidemiology and End Results (SEER) database
Si Shi et al.
TRANSLATIONAL CANCER RESEARCH (2021)
Efficacy and safety of 188Re-HEDP in lung cancer patients with bone metastases: a randomized, multicenter, multiple-dose phase IIa study
Ping Chen et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)
Construction and Validation of Two Novel Nomograms for Predicting the Overall Survival and Cancer-Specific Survival of NSCLC Patients with Bone Metastasis
Qiu Dong et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)
Outcome of Non-small Cell Lung Cancer Patients With N3 Stage: Survival Analysis of Propensity Score Matching With a Validated Predictive Nomogram
Chang Han et al.
FRONTIERS IN SURGERY (2021)
The incidence, risk factors and predictive nomograms for early death of lung cancer with synchronous brain metastasis: a retrospective study in the SEER database
Heng Shen et al.
BMC CANCER (2021)
Efficacy and safety of first-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) combined with chemotherapy or antiangiogenic therapy as first-line treatment in patients with EGFR-mutant non-small cell lung cancer: A systematic review and meta-analysis
Yuzhong Chen et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)
Current and Future Development in Lung Cancer Diagnosis
Reem Nooreldeen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Lung Cancer 2020 Epidemiology, Etiology, and Prevention
Brett C. Bade et al.
CLINICS IN CHEST MEDICINE (2020)
Establishment of a serological molecular model for the early diagnosis and progression monitoring of bone metastasis in lung cancer
Xiaoyan Teng et al.
BMC CANCER (2020)
Nomogram based on homogeneous and heterogeneous associated factors for predicting bone metastases in patients with different histological types of lung cancer
Chao Zhang et al.
BMC CANCER (2019)
Incidence, prognostic factors, and a nomogram of lung cancer with bone metastasis at initial diagnosis: a population-based study
Xuan-Qi Zheng et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2019)
Impact of the homogeneous and heterogeneous risk factors on the incidence and survival outcome of bone metastasis in NSCLC patients
Qian Song et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
Low-dose computed tomography screening reduces lung cancer mortality
Marcin Ostrowski et al.
ADVANCES IN MEDICAL SCIENCES (2018)
Recent advances in the management of lung cancer
Gavin S. Jones et al.
CLINICAL MEDICINE (2018)
The prognostic analysis of different metastatic patterns in extensive-stage small-cell lung cancer patients: a large population-based study
Hongchao Cai et al.
FUTURE ONCOLOGY (2018)
Choosing Wisely at the End of Life: Use of Shorter Courses of Palliative Radiation Therapy for Bone Metastasis
Audrey S. Wallace et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Simple staging system for osteosarcoma performs equivalently to the AJCC and MSTS systems
Justin M. M. Cates
JOURNAL OF ORTHOPAEDIC RESEARCH (2018)
Lung cancer: current therapies and new targeted treatments
Fred R. Hirsch et al.
LANCET (2017)
Palliative radiation therapy in the last 30 days of life: A systematic review
Kyung Ran Park et al.
RADIOTHERAPY AND ONCOLOGY (2017)
The risk factors of bone metastases in patients with lung cancer
Yang Zhou et al.
SCIENTIFIC REPORTS (2017)
Assessing the Clinical Impact of Risk Prediction Models With Decision Curves: Guidance for Correct Interpretation and Appropriate Use
Kathleen F. Kerr et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests
Andrew J. Vickers et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests
Andrew J. Vickers et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Nomograms in oncology: more than meets the eye
Vinod P. Balachandran et al.
LANCET ONCOLOGY (2015)
Bone health in cancer patients: ESMO Clinical Practice Guidelines
R. Coleman et al.
ANNALS OF ONCOLOGY (2014)
Metastatic sites and survival in lung cancer
M. Riihimaeki et al.
LUNG CANCER (2014)
Bone and brain metastasis in lung cancer: recent advances in therapeutic strategies
Chiara D'Antonio et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2014)
Comparison of diagnostic ability between 99mTc-MDP bone scan and 18F-FDG PET/CT for bone metastasis in patients with small cell lung cancer
Jeong Won Lee et al.
ANNALS OF NUCLEAR MEDICINE (2012)
Prevention and Management of Bone Metastases in Lung Cancer A Review
Hamed Al Husaini et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Predictors of survival in patients with bone metastasis of lung cancer
Hideshi Sugiura et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2008)
Clinical features of metastatic bone disease and risk of skeletal morbidity
Robert E. Coleman
CLINICAL CANCER RESEARCH (2006)